← Back
Data updated: Mar 10, 2026
EVIVE BIOTECHNOLOGY
Oncology
EVIVE BIOTECHNOLOGY is a biotechnology company focused on Oncology.
2023
Since
1
Drugs
-
Trials
0
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
0 drugs Phase 3: 3
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2023-11-16
- Latest
- 2023-11-16
- Applications
- 1